The client, with an established national field sales footprint, looked to partner to improve the stagnant sales trajectory for their I/O delivery device.
A field team of 16 DSAs (diabetes representatives) was overlayed to existing team to support high and medium-value targets to improve impact and call frequency.
DSAs’ goals also included elevating brand perception not just to the targeted HCPs but through a total account call to maximize pull-through adjacent to clinical selling.
Within the first four months of the added team, high-value DSA targets were averaging 3.5 more Rxs per target compared to the control group.
Average DSA had 21% more call activity (and 12% more sampling) than incumbent team.
Call activity (reach and frequency) was improved while contributing to a significant improvement in the cost per call (82% savings) for DSA targets.
Qualitative (market effectiveness surveys) feedback also showed improved brand and message recall and DSA satisfaction.
Wave 1:
93% of respondents state that they are ‘very satisfied’ with their DSA.**
**7% state that they are ‘satisfied’.
Jump to a slide with the slide dots.
CASE STUDY (CANADA) Inizio Engage delivered a patient-first, flexible model for a once-monthly injectable launch in Canada.
Read moreCASE STUDY (CANADA) Discover how Inizio Engage transformed an underperforming sales force in Canada.
Read moreNuvera expands its data-driven solutions and strengthens its leadership team to enhance patient and HCP treatment experiences.
Read more